bevacizumab
Third Biosimilar to Bevacizumab Approved
The FDA approved bevacizumab-maly (Alymsys, Amneal Pharmaceuticals), a biosimilar to bevacizumab (Avastin, ...
APRIL 19, 2022
FDA Approves Avastin Plus Chemo for Certain Women With Advanced Ovarian Cancer
The FDA granted a new indication for Avastin in combination with chemotherapy, followed by Avastin as a single ...
JUNE 18, 2018
FDA Gives Full Approval to Avastin for Recurrent GBM
The FDA has granted full approval for bevacizumab (Avastin, Genentech) for the treatment of adults with ...
DECEMBER 7, 2017
Novel Agent Produces Highest OS to Date in PRmCC
National Harbor, Md.—Data from a multicenter trial of a novel targeted immunotherapy for the treatment of ...
JULY 14, 2017
Combination Therapy Shows Promise in mRCC
The combination of atezolizumab (Tecentriq, Genentech) and bevacizumab (Avastin, Genentech) appears to be a ...
JUNE 28, 2017
VEGF Biomarker Not Predictive of Bevacizumab + Paclitaxel Efficacy
Adding bevacizumab to paclitaxel significantly improved PFS over placebo in patients with HER2-negative mBC, but an ...
FEBRUARY 13, 2017
Bevacizumab + CAPOX Improves QOL After Resection of CRC Liver Mets
Adding bevacizumab to an adjuvant regimen of capecitabine and oxaliplatin (CAPOX) may improve the quality of life ...
JANUARY 30, 2017
Avastin Plus CT Approved for Platinum-Sensitive Advanced Ovarian Ca
The approved is for use of bevacizumab in combination with carboplatin-paclitaxel or carboplatin-gemcitabine, ...
DECEMBER 7, 2016
Pediatric STS Response Rates Improve With Bevacizumab Plus Chemotherapy
Data presented at ASCO 2016 revealed mixed findings when bevacizumab is added to conventional chemotherapy for the ...
JULY 29, 2016